Weekly high-dose liposomal amphotericin b (l-amb) in critically ill septic patients with multiple candida colonization: the ambidex study

HIGHLIGHTS

• who: Elie Azoulay and collaborators from the , Louis University Hospital, Paris, France, and Infectious Diseases, Paris have published the article: Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0177093]. May 22, 2017 of October/31,/2016
• what: The aim of the study was to demonstrate feasibility and safety of weekly high-dose L-AmB for 2 weeks in a preemptive strategy in critically ill patients with ICU acquired sepsis and Candida . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.